Neurorestorative Effects of a Novel Fas-Associated Factor 1 Inhibitor in the MPTP Model: An [18 F]FE-PE2I Positron Emission Tomography Analysis Study

Frontiers in Pharmacology
Hyun Soo ParkSang Eun Kim

Abstract

Fas-associated factor 1 (FAF1), a Fas-binding protein, is implicated in neuronal cell death in Parkinson's disease (PD). We examined the effects of a novel FAF1 inhibitor, KM-819, in dopaminergic neurons in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model using [18F]FE-PE2I positron emission tomography (PET). The MPTP model was generated with subacute MPTP treatment (20 mg/kg/day, i.p.) for 5 consecutive days in C57bl/6J mice. This study included three groups: the control group (treatment with saline only), the MPTP model group with KM-819 treatment (20 mg/kg/day p.o.) for 6 days, and the MPTP model group without KM-819 treatment. [18F]FE-PE2I PET studies were conducted in the same animals before and after MPTP with or without KM-819 treatment to monitor changes in striatal dopamine transporter activity indicated by non-displaceable binding potential (BPND) of [18F]FE-PE2I, and the expression levels of tyrosine hydroxylase were assessed using immunohistochemistry before and after KM-819 treatment. After MPTP injection, decreased striatal BPND was observed in the MPTP model group compared with the control group. Striatal BPND increased in the MPTP model group with KM-819 treatment, but not in the MPTP model grou...Continue Reading

References

Jun 1, 1993·British Journal of Pharmacology·M Del ZompoA Vaccari
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·K ChuL T Williams
Aug 15, 1998·Biochemical and Biophysical Research Communications·Y MitsumotoN Koga
May 29, 2000·The New England Journal of Medicine·C B LückingUNKNOWN European Consortium on Genetic Susceptibility in Parkinson's Disease
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN Quinn
Nov 20, 2001·International Journal of Oncology·B GuerraO G Issinger
Mar 27, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nirit LevDaniel Offen
Apr 1, 2003·Annals of Neurology·William G TattonNadine Tatton
Apr 19, 2003·The Journal of Biological Chemistry·Seung-Wook RyuEunhee Kim
Sep 16, 2003·Neuron·William Dauer, Serge Przedborski
Sep 16, 2003·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Masanori IchiseRichard E Carson
Mar 4, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Aurelija JucaiteLars Farde
Apr 12, 2006·Archives of Neurology·Lorraine N ClarkKaren Marder
Apr 3, 2007·Nature Protocols·Vernice Jackson-Lewis, Serge Przedborski
Jun 25, 2008·Neurobiology of Disease·Ranjita BetarbetAllan I Levey
Oct 22, 2008·Oncogene·J W Yu, Y Shi
Jul 7, 2009·Bioorganic & Medicinal Chemistry Letters·Magnus SchouChrister Halldin
May 1, 2010·Metabolic Brain Disease·Hayato KuroiwaTsutomu Araki
Jan 7, 2011·Parkinson's Disease·J A PotashkinN K Runkle
May 13, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jeong Sook Kim-HanKaren L O'Malley
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·C Warren OlanowKarl Kieburtz
Jun 13, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Takeshi SasakiTetsuya Suhara
Jul 26, 2015·Progress in Neurobiology·Matthieu F BastideErwan Bézard
Aug 27, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Karl Kieburtz, C Warren Olanow
Feb 14, 2016·Nuclear Medicine and Biology·Ji-In BangSang Eun Kim
Jun 27, 2017·Acta Pharmacologica Sinica·Qiu-Shuang ZhangNai-Hong Chen
Oct 31, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Weihua LiPaola Piccini
May 3, 2018·Frontiers in Aging Neuroscience·Xian-Si ZengPeng-Peng Zhang
Sep 29, 2018·Nature Reviews. Drug Discovery·Delphine CharvinOlivier Rascol

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination

Software Mentioned

GraphPad
ImageJ
Prism
Image
Pro Plus
PMOD

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.